Lidocaine Hydrochloride and Epinephrine Injection USP: Affected lot may contain particles.
Last updated
Summary
Product
Lidocaine Hydrochloride and Epinephrine Injection USP
Issue
Health products - Product quality
What to do
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Distribution
National
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot number |
|---|---|---|---|---|---|
PFIZER CANADA ULC |
Lidocaine Hydrochloride and Epinephrine Injection USP |
DIN 01901915 |
Solution |
Lidocaine 2% & Epinephrine 1:100 |
LM4487 |
Issue
Affected lot may contain particles.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Health Care Establishments
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Pfizer Canada ULC 17300 Trans-Canada Highway, Kirkland, Quebec, H9J 2M5
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type I
Identification number
RA-77357
Get notified
Receive notifications for new and updated recalls and alerts by category.